HighTower Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
+8,490
New +$239K ﹤0.01% 3412
2015
Q2
Sell
-86,791
Closed -$1.11M 1552
2015
Q1
$1.11M Hold
86,791
0.02% 764
2014
Q4
$1.08M Hold
86,791
0.02% 763
2014
Q3
$799K Buy
+86,791
New +$1.38M 0.01% 853

Other funds holding ATRC

HighTower Advisors's ATRC Position: Q2 2026 in Review

HighTower Advisors opened a new position in AtriCure (ATRC) in Q2 2026: 8,490 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #3412 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in ATRC as recently as Q1 2015.

HighTower Advisors first reported a position in ATRC in Q3 2014 and has held it in 4 quarters since. The position peaked at $1.11M in Q1 2015. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • HighTower Advisors held 8,490 shares of AtriCure worth $238K as of Q2 2026.
  • AtriCure was a new HighTower Advisors position in Q2 2026.
  • AtriCure made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3412 holding.
  • HighTower Advisors first reported a position in AtriCure in Q3 2014 and has held it in 4 quarters since.
  • HighTower Advisors's AtriCure position peaked at $1.11M in Q1 2015.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.